Latest Regulatory News

Invion Limited’s IVXO securities have been suspended from ASX quotation due to non-compliance with key listing rules, raising questions about the company’s regulatory standing and investor confidence.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Pharmx Technologies has extended its pivotal National Diabetes Services Scheme agreement and expanded its supplier base, reinforcing its leadership in pharmacy digital infrastructure across Australia and New Zealand.

Spacetalk Ltd has raised $3 million through convertible notes from its largest shareholder and converted $1 million of secured debt, positioning the company for international growth and new product development.

Coda Minerals has submitted the Draft Scoping Report for its Elizabeth Creek Copper-Cobalt Project, marking a pivotal step in securing mining lease approvals in South Australia. This milestone reduces regulatory uncertainty and sets a clear path toward project development.

Johns Lyng Group has entered a binding scheme implementation deed with Pacific Equity Partners for a $1.1 billion acquisition at $4.00 per share, representing a significant premium and a 10.3x EV/EBITDA multiple. The transaction awaits shareholder and regulatory approvals, with major shareholder backing and a clear timetable set for late 2025.

Rey Resources Limited has dispatched its Target's Statement recommending shareholders accept an unconditional $0.028 per share cash offer from Vigorous Resources Pty Ltd. The bid, which offers a significant premium over historical prices, opens on 9 July and closes on 11 August 2025.

AML3D Limited has confirmed it complied with ASX continuous disclosure rules regarding its recent Letter of Intent with the US Navy, clarifying the timing of its awareness and announcement.

Hydralyte USA has completed its Rights Issue by placing 5 million shortfall shares, raising a total of $608,878 before costs. The move finalizes the company’s recent capital raising efforts under full regulatory compliance.

Lowell Resources Fund updates its estimated FY25 dividend to AUD 0.0274 per unit with a partly franked component, alongside a revised distribution reinvestment plan price at a 10% discount.

Yowie Group has decided not to proceed with its planned takeover bid for Keybridge Capital after a key condition was triggered, signaling a strategic retreat.

Bryah Resources has lodged a formal application with the Takeovers Panel alleging breaches of takeover laws by shareholders linked to GBA Capital and Yonglu Yu, amid a looming boardroom showdown.